81 related articles for article (PubMed ID: 10094544)
1. Cholesterol: how low is low enough? Doctors have been slow in getting evidence on lowering cholesterol into practice.
Wierzbicki AS; Reynolds TM
BMJ; 1999 Feb; 318(7182):539. PubMed ID: 10094544
[No Abstract] [Full Text] [Related]
2. Cholesterol alert.
Smith IK
Time; 2001 May; 157(21):90. PubMed ID: 11393039
[No Abstract] [Full Text] [Related]
3. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
4. Effect of combining psyllium fiber with simvastatin in lowering cholesterol.
Moreyra AE; Wilson AC; Koraym A
Arch Intern Med; 2005 May; 165(10):1161-6. PubMed ID: 15911730
[TBL] [Abstract][Full Text] [Related]
5. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Mikhailidis DP; Wierzbicki AS
Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011
[No Abstract] [Full Text] [Related]
6. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Garmendia F; Brown AS; Reiber I; Adams PC
Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
[TBL] [Abstract][Full Text] [Related]
7. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
8. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
[TBL] [Abstract][Full Text] [Related]
9. The cholesterol hypothesis: questioned?
Somberg JC; Molnar J
Am J Ther; 2008; 15(3):292-5. PubMed ID: 18496268
[No Abstract] [Full Text] [Related]
10. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
Farnier M
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317
[TBL] [Abstract][Full Text] [Related]
11. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.
Averbuch M; Ayalon D; Eckstein N; Dotan I; Shapira I; Levo Y; Pines A
J Med; 1998; 29(5-6):343-50. PubMed ID: 10503169
[TBL] [Abstract][Full Text] [Related]
13. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
Olsson AG; Nilsson PM
Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
[No Abstract] [Full Text] [Related]
14. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
15. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
16. Statin therapy for prevention of coronary artery disease with average cholesterol levels.
Gambhir DS
Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772
[No Abstract] [Full Text] [Related]
17. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol.
Fraunberger P; Gröne E; Gröne HJ; Walli AK
Shock; 2009 Aug; 32(2):159-63. PubMed ID: 19008785
[TBL] [Abstract][Full Text] [Related]
18. [Inegy: a powerful new medication for lowering LDL cholesterol].
Rev Med Suisse; 2006 Jun; 2(70):1605. PubMed ID: 16838729
[No Abstract] [Full Text] [Related]
19. [Hypercholesterolemia in high risk patients. Targeting low goal values].
MMW Fortschr Med; 2001 Apr; 143(15):50-1. PubMed ID: 11349323
[No Abstract] [Full Text] [Related]
20. Split thinking on low cholesterol and heart failure. Even though low cholesterol may signal trouble for people with heart failure, taking a cholesterol-lowering statin may help.
Harv Heart Lett; 2004 Jul; 14(11):6. PubMed ID: 15273049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
